PSPC1 and ovarian carcinoma: Next, we carried out a cell proliferation assay with PSPC1 siRNA (5 nM) and various concentrations of olaparib in BRCA-mutated breast (BT−474, MDA-MB−436) and ovarian cancer (SNU-251, PEO1) cells.